DK1204422T3 - Stress-proteiner fra extra-cellulære patogener som vacciner mod sygdomsfremkaldende organismer - Google Patents

Stress-proteiner fra extra-cellulære patogener som vacciner mod sygdomsfremkaldende organismer

Info

Publication number
DK1204422T3
DK1204422T3 DK00954741.5T DK00954741T DK1204422T3 DK 1204422 T3 DK1204422 T3 DK 1204422T3 DK 00954741 T DK00954741 T DK 00954741T DK 1204422 T3 DK1204422 T3 DK 1204422T3
Authority
DK
Denmark
Prior art keywords
extra
vaccines against
against disease
stress proteins
cellular pathogens
Prior art date
Application number
DK00954741.5T
Other languages
English (en)
Inventor
Camilo Anthony Leo Selwyn Colaco
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Application granted granted Critical
Publication of DK1204422T3 publication Critical patent/DK1204422T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK00954741.5T 1999-08-19 2000-08-18 Stress-proteiner fra extra-cellulære patogener som vacciner mod sygdomsfremkaldende organismer DK1204422T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9919734.5A GB9919734D0 (en) 1999-08-19 1999-08-19 Vaccines from infectious agents
PCT/GB2000/003228 WO2001013944A2 (en) 1999-08-19 2000-08-18 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents

Publications (1)

Publication Number Publication Date
DK1204422T3 true DK1204422T3 (da) 2010-03-15

Family

ID=10859501

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00954741.5T DK1204422T3 (da) 1999-08-19 2000-08-18 Stress-proteiner fra extra-cellulære patogener som vacciner mod sygdomsfremkaldende organismer

Country Status (14)

Country Link
EP (1) EP1204422B1 (da)
JP (1) JP2003507431A (da)
CN (1) CN100523192C (da)
AT (1) ATE449610T1 (da)
AU (1) AU6709900A (da)
CA (1) CA2382336C (da)
DE (1) DE60043390D1 (da)
DK (1) DK1204422T3 (da)
ES (1) ES2336417T3 (da)
GB (1) GB9919734D0 (da)
IL (2) IL148153A0 (da)
PT (1) PT1204422E (da)
WO (1) WO2001013944A2 (da)
ZA (1) ZA200201359B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004547D0 (en) * 2000-02-23 2000-04-19 Immunobiology Ltd Screening method for novel vaccine candidates and compositions obtained thereby
GB0021757D0 (en) * 2000-09-04 2000-10-18 Colaco Camilo Vaccine against microbial pathogens
WO2009021291A1 (en) * 2007-08-16 2009-02-19 The University Of Sydney Mycobacterium vaccine formulation
GB0910591D0 (en) 2009-06-19 2009-07-29 Immunobiology Ltd Method for the purification of protein complexes
GB0916557D0 (en) 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB201104897D0 (en) 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same
CN110240636A (zh) * 2019-06-04 2019-09-17 华中农业大学 牛分枝杆菌分子伴侣蛋白GroEL1及其编码基因与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002564A1 (en) * 1988-09-12 1990-03-22 Codon Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
TR199701537T1 (xx) * 1995-06-07 1998-03-21 Biochem Vaccines Inc. HSP70 ailesinin streptokokal �s� �ok protein �yeleri.

Also Published As

Publication number Publication date
EP1204422B1 (en) 2009-11-25
ATE449610T1 (de) 2009-12-15
DE60043390D1 (de) 2010-01-07
WO2001013944A2 (en) 2001-03-01
IL148153A0 (en) 2002-09-12
ZA200201359B (en) 2003-07-30
JP2003507431A (ja) 2003-02-25
WO2001013944A3 (en) 2001-09-20
PT1204422E (pt) 2010-02-05
CA2382336C (en) 2012-07-10
CN100523192C (zh) 2009-08-05
AU6709900A (en) 2001-03-19
EP1204422A2 (en) 2002-05-15
GB9919734D0 (en) 1999-10-20
CA2382336A1 (en) 2001-03-01
IL148153A (en) 2011-04-28
ES2336417T3 (es) 2010-04-13
CN1556856A (zh) 2004-12-22

Similar Documents

Publication Publication Date Title
ATE272410T1 (de) Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
ATE442163T2 (de) Lawsonia intracellularis europäischen ursprungs und vakzine, diagnostika und anwendungsverfahren dafür
HK1077014A1 (en) Neisserial vaccine compositions comprising a combination of antigens
WO2004030608A3 (en) Nanoemulsion vaccines
CO5280094A1 (es) Un analogo de a o app y una composicion inmunogenica que comprende dicho analogo
NO20015073D0 (no) Vaksiner
DE602004028029D1 (en) Rwendung
DK1204422T3 (da) Stress-proteiner fra extra-cellulære patogener som vacciner mod sygdomsfremkaldende organismer
PT1112747E (pt) Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos
WO2001063278A3 (en) Antigenic fragments associated with stress-induced proteins and their use as vaccines
HK1080712A1 (en) Ihnv g protein for immune stimulation
WO2008153772A3 (en) Chlamydia vaccine comprising htra polypeptides
DK1315518T3 (da) Vaccine mod mikrobielle patogener
DK1204421T3 (da) Stressprotein-peptidkomplekser som vacciner mod intracellulære patogener
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
DE602005021873D1 (de) Neues impfstoffadjuvans und dessen herstellung und verwendung
EA200400534A1 (ru) Стимуляция тимозином генетической иммунизации
WO2006037383A8 (en) Piscirickettsia salmonis antigens and use thereof
DK1204420T3 (da) Trehaloseproducerende prokaryotiske celler som vacciner